Roivant Sciences Ltd (ROIV)
NASDAQ · Healthcare
Roivant Sciences Ltd Operating Income 2021–2026
Roivant Sciences Ltd annual/quarterly operating income history and growth rate from 2021 to 2025. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Roivant Sciences Ltd operating income for the quarter ending December 31, 2025 was -339.2 M, a 23.61% increase year-over-year.
- Roivant Sciences Ltd operating income for the twelve months ending December 31, 2025 was -1.2 B, a 126.95% decrease year-over-year.
- Roivant Sciences Ltd annual operating income for 2026 was -515.1 M, a 48.66% decrease from 2025.
- Roivant Sciences Ltd annual operating income for 2025 was -1.0 B, a 122.31% decrease from 2024.
- Roivant Sciences Ltd annual operating income for 2024 was 4.5 B, a 595.94% decrease from 2023.
- Roivant Sciences Ltd annual operating income for 2023 was -906.8 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Roivant Sciences Ltd Operating Income — FAQ
Roivant Sciences Ltd (ROIV) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Roivant Sciences Ltd's operating income?
Roivant Sciences Ltd (ROIV) reported operating income of -$515M for fiscal 2026.
Where can I see ROIV's operating income history?
The chart and table above show Roivant Sciences Ltd's operating income by year and by quarter, including the growth rate.